-
Results That MatterCancer medications granted accelerated approval are often confirmed despite not demonstrating a benefit in overall survival or quality of life.
by Eric Fitzsimmons
-
April 5: The Week in Cancer NewsMore cancer patients are enrolling in clinical trials, and sentinel node biopsies alone may be adequate for some early-stage breast cancers.
by Marci A. Landsmann
-
Genetic Testing for Women With Breast CancerNew recommendations clarify when women diagnosed with breast cancer should be offered genetic testing for inherited cancer risk.
by Laura Gesualdi-Gilmore
-
March 29: The Week in Cancer NewsSurvival rates have increased for older AML patients who receive stem cell transplants, and cervical cancer diagnoses rise among women living in low-income counties.
by Kevin McLaughlin
-
TIL Therapy Amplifies the Immune System’s Attack on MelanomaThe recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
by Sandra Gordon
-
March 22: The Week in Cancer NewsFirst CAR T-cell therapy approval in chronic lymphocytic leukemia, and Environmental Protection Agency announces a complete ban on asbestos use in manufacturing.
by Thomas Celona
-
Dealing With Immediate Medical Test ResultsPatients have been entitled to immediate access to medical records and test results for three years as a result of the Cures Act. It has changed how patients and doctors share information.
by Taneia Surles
-
March 15: The Week in Cancer NewsModified CAR T-cell therapy shows promise in glioblastoma, and an immunotherapy may soon be available as an injection.
by Eric Fitzsimmons
-
Empowering Pediatric Cancer PatientsAfter twice being treated for leukemia as a child, Brady Lucas discusses the mental impact of pediatric cancer.
by Suzanne McBride
-
March 8: The Week in Cancer NewsWhy do many Asian American women who have never smoked have lung cancer, and a report finds acne products can create cancer-causing benzine.
by Marci A. Landsmann
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
